Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole used as First-Line Treatment for Pneumocystis jirovecii Pneumonia

BACKGROUND: Trimethoprim/sufamethoxazole (TMP/SMX) is the recommended treatment for Pneumocystis jirovecii pneumonia (PCP). However, the efficacy and the safety of alternative salvage treatments are less guarauteed especially when patient experiences treatment failure and/or an adverse drug reaction...

全面介紹

Na minha lista:
書目詳細資料
發表在:Infect Chemother
Main Authors: Kim, Tark, Sung, Heungsup, Chong, Yong Pil, Kim, Sung-Han, Choo, Eun Ju, Choi, Sang-Ho, Kim, Tae Hyong, Woo, Jun Hee, Kim, Yang Soo, Lee, Sang-Oh
格式: Artigo
語言:Inglês
出版: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2018
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6031595/
https://ncbi.nlm.nih.gov/pubmed/29968978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3947/ic.2018.50.2.110
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍